No Data
No Data
When Will Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Turn A Profit?
Arcutis Biotherapeutics (ARQT) Surges 15.9%: Is This an Indication of Further Gains?
Watching Arcutis Biotherapeutics; Traders Circulate Unconfirmed Rumor From M&A Blog
Express News | Guggenheim Reiterates Buy on Arcutis Biotherapeuticsto Buy
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Express News | Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
MommaCrazy : give it time... they may short it down to steal a ton of shares. They do this on ARQT and my dumb butt averaged up.